Sign up
Pharma Capital

The Hydroponics Company: Access latest PPT from Proactive's CEO Sessions

Dr Andrew Beehag talked medical cannabis products and pathways with investors.
The Hydroponics Company: Access latest PPT from Proactive's CEO Sessions
Dr Andrew Beehag, chief executive officer for Canndeo, on behalf of THC

The Hydroponics Company (ASX:THC) joined Proactive's CEO Sessions in Melbourne on Tuesday 16th May and Sydney on Wednesday 17th May.

Speaking was Dr Andrew Beehag, chief executive officer for Canndeo, a wholly-owned subsidiary of THC.

THC offers a range of equipment for cannabis cultivation and processing, as well as high-end next generation agricultural products across Australia, Asia, U.S. and Canada.

THC is one of the few medicinal cannabis companies to have a substantial growing revenue stream.

ACCESS THE FULL PRESENTATION HERE

View full THC profile

The Hydroponics Company Ltd Timeline

View All

Related Articles

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.